1. Analysis of Calcium Acetate Capsules According to USP-NF Method (YK-421)
  2. Analysis of Potassium and Sodium Bicarbonates and Citric Acid Effervescent Tablets for Oral Solution Proposed in USP-NF Pharmacopeial Forum (YK-421)
  3. Analysis of Potassium Bicarbonate and Potassium Chloride Effervescent Tablets for Oral Solution Proposed in USP-NF Pharmacopeial Forum (YK-421)
  4. Analysis of Zinc Sulfate Compounded Injection According to USP-NF Method (YK-421)
  5. Analysis of Pamidronate Disodium According to USP-NF Method (IC I-524A)
  6. Analysis of Zoledronic Acid (IC I-524A)
  7. Analysis of Sodium Ibandronate (IC I-524A)
  8. Analysis of Sodium Risedronate (IC I-524A)
  9. Analysis of Inositol According to Japanese Pharmaceutical Excipients 2018 (KS-801)
  10. SEC Analysis of Filgrastim (KW-803)
  11. Analysis of Coenzyme Q10 in a Dietary Supplement (C18P 4D)
  12. Analysis of Levocarnitine (NH2P-50 4E)
  13. Analysis of Oligomers in Omega-3 Free Fatty Acids According to USP-NF (KF-802.5 + KF-802 + KF801)
  14. LC/MS Analysis of Macrolide Antibiotics (C18U 2B)
  15. Analysis of Trypsin-Digested Rituximab (C18U 2D)
  16. Analysis of Allantoin in a Commercial Disinfectant (VG-50 4E)
  17. SEC Analysis of Liraglutide Formulation (KW-802.5)
  18. SEC Analysis of PEG-Asparaginase (SB-806 HQ)
  19. Analysis of Teriparatide According to EP Method (KW-802.5)
  20. Analysis of Azithromycin Injection According to USP Method (ODP-50 4E)
  21. Quantification of Alendronate Sodium Injection According to JP Method (DS-613)
  22. Quantification of Alendronate Sodium Tablets According to JP Method (DS-613)
  23. Quantification of Alendronate Sodium Hydrate According to JP Method (DS-413)
  24. Quantification of Alendronate Sodium Hydrate and Its Related Compound According to JP Method (DS-413)
  25. Analysis of Erythropoietin According to EP Method (LW-803)
  26. SEC Analysis of Rituximab (LW-803)
  27. Analysis of Somatropin According to EP Method (LW-803)
  28. Exenatide Analysis According to USP Method (KW-802.5)
  29. Analysis of α-GPC in Supplements (NH2P-50 4E)
  30. Ginsenoside (Carrot Saponin) (NH2P-50 4E)
  31. SEC Analysis of Saccharated Ferric Oxide Injection (SB-804 HQ + SB-802.5 HQ)
  32. Impurity Analysis of Lamivudine According to USP Method (CDBS-453)
  33. Impurity Analysis of Voriconazole According to USP Method (CDBS-453)
  34. Analysis of Formoterol Fumarate Dihydrate According to Pharmacopeia Method (ODP-50 4D)
  35. LC/MS/MS Analysis of Salacia Extract (2) (VT-50 2D)
  36. LC/MS/MS Analysis of Salacia Extract (1) (VC-50 2D)
  37. LC/MS/MS Analysis of Citicoline (VT-50 2D)
  38. LC/MS Analysis of Streptomycins (VC-50 2D)
  39. Comparison of Analysis of Glucosamine Hydrochloride between Polymer-based Amino Columns and Silica-based Amino Columns
  40. Assay of Polyethylene Glycol 3350 for Oral Solution According to USP Method (SB-802.5 HQ)
  41. Measurement of Apparent Weight-Average Molecular Weight and Polydispersity of Polyethylene Glycol 3350 According to USP Method (SB-803 HQ)
  42. LC/MS/MS Analysis of Salacia Extract (1) (VC-50 2D)
  43. LC/MS/MS Analysis of Ribavirin (VC-50 2D)
  44. Analysis of High Molecular Impurities in Insulin Aspart According to Pharmacopoeia Method (KW-802.5)
  45. Dissolution Test of Ribavirin Capsules according to JP Method (Y-521)
  46. LC/MS Analysis of Aminoglycoside Antibiotics (VC-50 2D)
  47. Drugs (ODP-50 4D)
  48. Soyasaponin in Soy Bean (DS-613)
  49. LC/MS/MS Analysis of Oral Anti-diabetes Drugs (VC-50 2D)
  50. Analysis of Voglibose According to JP Method (NH2P-50 4E)
  51. Analysis of Catechin (C18P 4D)
  52. Bibliographic Information for Analysis of Conjugate Vaccine
  53. Separation of Gingerol and Shogaol (C18M 4D)
  54. Analysis of Purified Sodium Hyaluronate Ophthalmic Solution According to JP Method (SB-802.5 HQ)
  55. Analysis of Miglitol According to JP Method (NH2P-50 4E)
  56. Analysis of Insulin According to USP Method (KW-802.5)
  57. Analysis of Insulin Glargine According to JP Method (KW-802.5)
  58. Analysis of Insulin Human According to JP Method (KW-802.5)
  59. Analysis of Zanamivir According to USP Method (NH2P-50 4E)
  60. Analysis of Glucosamine According to USP Method (5NH 4D)
  61. Analysis of Allantoin (JJ-50 4D)
  62. Analysis of Azithromycin According to USP Method (ODP-50 4E)
  63. LC/MS Analysis of Metformin (NH2P-40 2D)
  64. Simultaneous Analysis of Multi Symptom Cold Formula (ODP2 HP)
  65. Simultaneous Analysis of Multi Symptom Cold Formula in Serum (ODP2 HP)
  66. LC/MS Analysis of Statins (ODP2 HP-2B)
  67. LC/MS Analysis of Basic Drugs (ODP40-2D)
  68. Basic sample (Procainamide, N-Acetylprocainamide) (Shodex C18-4D)
  69. Coenzyme Q10
  70. Anti-diabetes drugs (NH2P-50 4E)
  71. Anticonvulsant (Shodex C18-4D)
  72. Paeoniflorin (Shodex C18-4D)
  73. Anti-inflammatory agent (Shodex C18-4D)
  74. Basic sample (Scopolamine, Atropine) (Shodex C18-4D)
  75. Berberine (Shodex C18-4D)
  76. Cold remedy (1) (Shodex C18-4D)
  77. Cold remedy (2) (Shodex C18-4D)
  78. Glycyrrhizin (Shodex C18-4D)
  79. Macrolide antibiotics and derivatives
  80. Ribavirin (KS-801)
  81. Ginsenoside (Ginseng Saponin)
  82. Short Amines (ODP2 HP-4D)
  83. Analysis of Short Amines without Using Ion Pair Reagent
  84. Procaine and Procaineamide (ODP-50 4D)
  85. Methylxanthine (1) (DS-613)
  86. Methylxanthine (2)
  87. Local Anesthetics (1) (ODP-50 4D)
  88. Local Anesthetics (2) (DE-413)
  89. Cinchona Alkaloids
  90. Antibiotics (1) (ODP-50 4D)
  91. Antibiotics (2) (DE-413)
  92. Sulfanilamides (DE-413)
  93. Barbiturates (ODP-50 4D)
  94. Effect of pH of Eluent on Sensitivity of Barbital
  95. Berberine in Japanese Goldthread
  96. Glycyrrhizin in Licorice
  97. Saikosaponins (ODP-50 6D)
  98. Soysaponin in Soy Beans (DS-613)
  99. Curative medicine to eradicate H.Pyrori
  100. Enalapril Maleate (DS-413)